Recombinant
RabMAb

Anti-Dihydrofolate reductase (DHFR) antibody [EPR5285] (ab124814)

Publishing research using ab124814? Please let us know so that we can cite the reference in this datasheet.

ab124814 has been referenced in 4 publications.

  • Shinojima N  et al. Clinical significance of polyglutamylation in primary central nervous system lymphoma. Acta Neuropathol Commun 6:15 (2018). WB . PubMed: 29475458
  • Hughes L  et al. An active second dihydrofolate reductase enzyme is not a feature of rat and mouse, but they do have activity in their mitochondria. FEBS Lett 589:1855-62 (2015). WB ; Rat . PubMed: 25980602
  • Allen MD  et al. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res 74:896-907 (2014). PubMed: 24285724
  • Garon EB  et al. The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. Mol Cancer Ther 12:890-900 (2013). PubMed: 23493311

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up